Related Experiment Video
Updated: Jun 20, 2026
International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
Published on: March 12, 2020
Assessment of the burden of paediatric empyema in Australia
Roxanne Strachan1, Adam Jaffé,
1Department of Respiratory Medicine, Sydney Children's Hospital, High Street, Randwick, New South Wales 2031, Australia.
Insights
Childhood empyema incidence is rising in Australia, particularly in younger children, mirroring global trends. Management varies significantly across hospitals, highlighting a need for national guidelines.
Area of Science:
- Pediatric Infectious Diseases
- Respiratory Medicine
- Public Health Surveillance
Background:
- Childhood empyema and pneumonia represent significant pediatric respiratory illnesses.
- Understanding incidence trends and management practices is crucial for effective healthcare delivery.
Purpose of the Study:
- To investigate changes in childhood empyema and pneumonia incidence in Australia.
- To analyze current management trends for pediatric empyema across Australian hospitals.
Main Methods:
- Retrospective analysis of the Australian National Hospital Morbidity Database (1993/1994–2004/2005).
- Utilized ICD-9 and ICD-10 diagnostic codes for patients under 20 years.
- Surveyed hospitals with pediatric beds regarding referral patterns and treatment preferences.
Main Results:
- Pneumonia incidence showed a non-significant overall increase, but a significant rise in 1-4 year olds.
- Empyema incidence significantly increased overall, driven by increases in 1-4 and 15-19 year olds.
- The proportion of pneumonia cases that were empyema rose from 0.27% to 0.70%; 82% of hospitals referred empyema cases, with varied treatments.
Conclusions:
- The increasing incidence of childhood empyema in Australia aligns with international observations.
- Diverse management practices indicate a critical need for standardized national guidelines for pediatric empyema care.
Aims:
To investigate the change in incidence of childhood empyema and pneumonia in Australia, and ascertain the management trends in all hospitals caring for children with empyema.
Methods:
The incidences of empyema and pneumonia were calculated for each year between 1993/1994 and 2004/2005 using retrospective primary diagnostic coding from ICD-9 and 10 comprising the Australian National Hospital Morbidity Database for five age groups in patients less than 20 years of age. Hospitals with allocated paediatric beds were surveyed on referral pattern and treatment preferences.
Results:
In this study, 145 562 patients with pneumonia were admitted with a mean (range) incidence of 2306 (1846-2652) per million. The trend towards an overall increase was not statistically significant. Only the 1-4 years old age group demonstrated a significant increase (P < 0.01, r2 = 0.61). A total of 469 cases of empyema were identified with a mean incidence of 7.35 (4-10.2) per million. There was an overall increase in incidence (P < 0.05, r2 = 0.51) reflecting an increase in the 1- to 4-year-olds (P < 0.005, r2 = 0.60) and 15- to 19-year-olds (P < 0.05, r2 = 0.37). The overall percentage of empyema as a proportion of pneumonia increased from 0.27 to 0.70% (0.48% (0.27-0.70%), P < 0.05, r2 = 0.38). The survey response rate was 75%. Ninety-nine of 121 (82%) hospitals referred children with empyema to a more appropriate centre with wide variations in treatments provided.
Conclusions:
The rise in incidence of empyema reflects that seen in other countries. Furthermore, there are diverse management practices suggesting a clear need for national guidelines.
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
01:29Pneumonia I: Introduction
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:23Assessment of Respiration
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like asthma or COPD,...
01:28Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: